Search

everythinglearnresearchcommunity

for

Search:↓

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Cyproterone acetate effectively treats female hair loss by increasing healthy hair and decreasing unhealthy hair, but doesn't change hair thickness.

Low serum ferritin levels are linked to specific types of hair loss in women.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with early onset androgenetic alopecia have worse lipid profiles.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

Many women with seborrheic dermatitis also have acne and diabetes, and should be checked for these conditions to help improve their quality of life.

About 61% of women who had COVID-19 experienced hair loss afterward.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Twisted hair is rare in severe anorexia nervosa, found in only 2 out of 30 patients.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

Advancements in technology now allow better evaluation and treatment for women with common hair loss problem, androgenic alopecia.

Microneedling with platelet-rich plasma can cause temporary, painful lymph node swelling in some patients.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with PCOS are much more likely to experience depression.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Diffuse hair loss significantly worsens quality of life for females, especially younger women and those with long-term hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.